Effect of Sodium Thiosulfate on Cisplatin Removal With Complete Hepatic Venous Isolation and Extracorporeal Charcoal Hemoperfusion: A Pharmacokinetic Evaluation

[1]  Y. Kuroda,et al.  Regional pharmacokinetics of doxorubicin following hepatic arterial and portal venous administration: evaluation with hepatic venous isolation and charcoal hemoperfusion. , 1998, Cancer research.

[2]  E. Neuwelt,et al.  First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate. , 1998, The Journal of pharmacology and experimental therapeutics.

[3]  Y. Kuroda,et al.  Induction of long-term remission in advanced hepatocellular carcinoma with percutaneous isolated liver chemoperfusion. , 1998, Annals of surgery.

[4]  Y. Kuroda,et al.  Single catheter technique of hepatic venous isolation and extracorporeal charcoal hemoperfusion for malignant liver tumors. , 1997, American journal of surgery.

[5]  Y. Kuroda,et al.  Clinical pilot study on high-dose intraarterial chemotherapy with direct hemoperfusion under hepatic venous isolation in patients with advanced hepatocellular carcinoma. , 1995, Surgery.

[6]  A. Gabizon,et al.  Reduction of the systemic toxicity of cisplatin by intra‐arterial hepatic route administration for liver malignancies , 1995, International journal of cancer.

[7]  T. Ravikumar,et al.  Percutaneous hepatic vein isolation and high-dose hepatic arterial infusion chemotherapy for unresectable liver tumors. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  O. Dalesio,et al.  Phase II trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy--a phase II study of the EORTC Gynaecological Cancer Cooperative Group. , 1994, European journal of cancer.

[9]  H. Malmström,et al.  Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer. , 1993, Gynecologic oncology.

[10]  Y. Kuroda,et al.  [Comparison of hepatic tissue extraction rates of cytotoxic anticancer drugs during hepatic arterial chemotherapy--evaluation using direct hemoperfusion under hepatic venous isolation]. , 1993, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[11]  J. Lewis,et al.  Phase II trial of high-dose cisplatin with sodium thiosulfate nephroprotection in patients with advanced carcinoma of the uterine cervix previously untreated with chemotherapy. , 1991, Gynecologic oncology.

[12]  M. Esposito,et al.  Liver and tumor uptake and plasma pharmacokinetic of arterial cisplatin administered with and without starch microspheres in patients with liver metastases , 1991, Cancer.

[13]  S. Curley,et al.  Hepatic arterial infusion chemotherapy with complete hepatic venous isolation and extracorporeal chemofiltration: a feasibility study of a novel system , 1991, Anti-cancer drugs.

[14]  H. Ohyanagi,et al.  Extracorporeal removal of anticancer drugs in hepatic artery infusion: the effect of direct hemoperfusion combined with venovenous bypass. , 1990, Surgery.

[15]  K. Masuhara,et al.  High-performance liquid chromatographic analysis of unchanged cis-diamminedichloroplatinum (cisplatin) in plasma and urine with post-column derivatization. , 1990, Journal of chromatography.

[16]  S. Howell,et al.  Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin. , 1989, Journal of the National Cancer Institute.

[17]  H. Ohyanagi,et al.  [Extracorporeal adriamycin-removal following hepatic artery infusion: use of direct hemoperfusion combined with veno-venous bypass]. , 1989, Nihon Geka Gakkai zasshi.

[18]  T. Akiyoshi,et al.  'Two-route chemotherapy' using intra-arterial cisplatin and intravenous sodium thiosulfate, its neutralizing agent, for hepatic malignancies. , 1988, European journal of cancer & clinical oncology.

[19]  H. Pinedo,et al.  Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding. , 1986, Clinical chemistry.

[20]  K. Wilms,et al.  [Therapy of peritoneal carcinosis with intraperitoneal administration of cis-diamminedichloroplatinum and systemic sodium thiosulfate protection. Clinical results of a pilot study and pharmacokinetics]. , 1985, Onkologie.

[21]  M. Hirano,et al.  [Pharmacokinetics of cisplatin and the effect of sodium thiosulfate]. , 1984, Gan to kagaku ryoho. Cancer & chemotherapy.

[22]  T. N. Campbell,et al.  Clinical pharmacokinetics of intraarterial cisplatin in humans. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  R. Olshen,et al.  Intraperitoneal cis-diamminedichloroplatinum with systemic thiosulfate protection. , 1983, Cancer research.

[24]  A. Ivankovich,et al.  Sodium Thiosulfate Disposition in Humans: Relation to Sodium Nitroprusside Toxicity , 1983, Anesthesiology.

[25]  R. Olshen,et al.  Intraperitoneal cisplatin with systemic thiosulfate protection. , 1982, Annals of internal medicine.

[26]  S. Wallace,et al.  Phase I‐II trial of percutaneous intra‐arterial Cis‐diamminedichloro platinum (II) for regionally confined malignancy , 1980, Cancer.

[27]  A. Guarino,et al.  Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. , 1977, Biochemical medicine.